a company, which engages in researching and developing biotechnology
Industry Biotechnology
A.I.dvisor tells us that INBX and ARQT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INBX and ARQT's prices will move in lockstep.
Ticker / NAME | Correlation To INBX | 1D Price Change % | ||
---|---|---|---|---|
INBX | 100% | -7.25% | ||
ARQT - INBX | 32% Poorly correlated | -5.16% | ||
CHRS - INBX | 31% Poorly correlated | -0.78% | ||
ADPT - INBX | 31% Poorly correlated | -4.62% | ||
PMVP - INBX | 31% Poorly correlated | -3.03% | ||
IMTX - INBX | 30% Poorly correlated | -0.47% | ||
More |
Ticker / NAME | Correlation To INBX | 1D Price Change % |
---|---|---|
INBX | 100% | -7.25% |
therapeutic theme (4 stocks) | 92% Closely correlated | -2.89% |
infectious diseases theme (2 stocks) | 70% Closely correlated | -7.51% |
oncology theme (18 stocks) | 33% Loosely correlated | -2.87% |
biotechnology theme (238 stocks) | 15% Poorly correlated | -4.32% |